Celgene to buy Juno for $9 billion

Celgene announced a $9 billion cash buyout of Juno Therapeutics as it moves to cement its position as a key player in a new range of cancer therapies. Aleksandra Michalska reports.

Save videos for later by signing up or logging in

With "My Queue" you can quickly save videos to watch later.

To add an item to your queue just click the sign next to the video.

Once you've added a video visit "My Queue" to start watching!